Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ANCHOR Study: Anal Cancer/HSIL Outcomes Research Study

NCT02135419 is registered in ClinicalTrials.gov with AIDS Malignancy Consortium as lead sponsor.

NCT NCT02135419
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02135419 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ANCHOR Study: Anal Cancer/HSIL Outcomes Research Study
Lead sponsor
AIDS Malignancy Consortium
Phase
Phase 3
Overall status
Completed
Start date
September 24, 2014
Completion date
March 31, 2024
Enrollment
4,446 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

anal cancer, high-grade squamous intraepithelial lesion, hiv infection, human papilloma virus infection